Actos (Pioglitazone) Cost in Kansas 2026

Kansas Retail Pricing for Pioglitazone in 2026

The average cash-pay price for generic pioglitazone across Kansas retail pharmacies sits at $15 per month for a 30-tablet supply in 2026. That figure represents the uninsured, no-coupon price at chains like CVS, Walgreens, Walmart, and Dillons (Kroger) locations throughout Wichita, Overland Park, Topeka, and Lawrence.

Brand-name Actos carries a manufacturer list price of $60 per month from Takeda Pharmaceuticals. Because multiple generic manufacturers (Teva, Mylan, Sun Pharma, and others) have produced pioglitazone since 2012, market competition has driven retail pricing to roughly 75% below the branded product. A 90-day supply at many Kansas pharmacies ranges from $35 to $50, making quarterly fills even more economical per tablet. Walmart's $4 generic list includes pioglitazone 15 mg and 30 mg in some Kansas locations, though availability varies by store and should be confirmed at the pharmacy counter 1.

Pricing differences between Kansas cities are minimal. Pharmacies in rural western Kansas towns like Dodge City or Garden City generally match metro pricing within $2 to $4 per month because wholesale acquisition costs for this high-volume generic are standardized nationally.

Kansas Medicaid Coverage

Kansas Medicaid (KanCare, administered through Aetna Better Health, Sunflower Health Plan, and United Healthcare Community Plan) covers pioglitazone for its FDA-approved indication of type 2 diabetes mellitus. The drug appears on the Kansas Medicaid preferred drug list as a generic thiazolidinedione.

Off-label use for nonalcoholic steatohepatitis (NASH), now termed metabolic dysfunction-associated steatohepatitis (MASH), is not covered under KanCare. This matters because the PIVENS trial (N=247) demonstrated that pioglitazone 30 mg daily produced histological improvement in NASH in 34% of subjects versus 19% on placebo over 96 weeks 2. Clinicians prescribing for MASH in Kansas Medicaid patients will need to pursue a prior authorization exception or direct the patient toward cash-pay pricing, which remains affordable at $15 per month.

KanCare copays for preferred generic drugs are $1 to $4 per prescription for most beneficiaries. Patients enrolled in the medically needy spend-down pathway face no copay once their spend-down obligation is met. Kansas Medicaid does not require step therapy through metformin before approving pioglitazone, though most prescribers initiate metformin first per American Diabetes Association Standards of Care guidelines 3.

Commercial Insurance Coverage in Kansas

Most commercial plans sold on the Kansas Health Insurance Marketplace (healthcare.gov) and employer-sponsored plans in Kansas place generic pioglitazone on Tier 1 (preferred generic). Typical Tier 1 copays in Kansas range from $0 to $15 per fill.

Blue Cross Blue Shield of Kansas covers pioglitazone without prior authorization. Aetna, Cigna, and UnitedHealthcare plans available in the Kansas City metro and statewide employer pools similarly list pioglitazone as a preferred generic with no quantity limits at standard doses (15 mg, 30 mg, or 45 mg, quantity 30 per month).

Brand-name Actos, if specifically prescribed with a "dispense as written" designation, falls on Tier 3 (non-preferred brand) for most Kansas plans, with copays between $40 and $75. Because the generic is therapeutically equivalent (AB-rated by the FDA), pharmacies in Kansas will automatically substitute unless the prescriber or patient explicitly requests brand.

The 2024 AACE/ACE Comprehensive Type 2 Diabetes Management Algorithm positions thiazolidinediones as second-line or third-line add-on therapy, noting pioglitazone's cardiovascular benefit signal from the PROactive trial (N=5,238), which showed a 16% reduction in the composite of all-cause mortality, non-fatal MI, and stroke (P=0.027) 4.

Compounded Pioglitazone in Kansas

Kansas permits licensed 503A compounding pharmacies to prepare pioglitazone formulations. A 503A pharmacy operates under a patient-specific prescription from a licensed prescriber, compounding medications that are not commercially available in the needed form or strength.

Practical applications in Kansas include:

• Liquid suspensions for patients who cannot swallow tablets (dysphagia, bariatric surgery patients with altered anatomy)
• Custom low-dose formulations (e.g., 7.5 mg for MASH protocols that use sub-therapeutic diabetes doses)
• Combination preparations with other agents when clinically appropriate

Kansas Board of Pharmacy regulations align with FDA guidance under section 503A of the Federal Food, Drug, and Cosmetic Act. Compounding pharmacies must maintain a valid Kansas pharmacy license, compound from bulk drug substances listed in the FDA's drug master file, and dispense only pursuant to a valid prescription.

Cost for compounded pioglitazone varies. Some 503A pharmacies in Kansas offer compounded formulations at minimal markup because pioglitazone powder is inexpensive as a raw ingredient. Patients should request pricing directly from Kansas-licensed compounding pharmacies such as those in the Professional Compounding Centers of America (PCCA) network.

Telehealth Access in Kansas

Kansas law permits prescribing pioglitazone via telehealth. The state does not require an in-person visit before initiating a new prescription for Schedule VI (non-controlled) medications. Pioglitazone is not a controlled substance, so telehealth prescribers face no DEA-related barriers to e-prescribing across Kansas.

Kansas adopted permanent telehealth parity legislation (SB 379) that requires commercial insurers to reimburse telehealth visits at the same rate as in-person encounters. This means a patient in Salina, Hutchinson, or any rural Kansas county can establish care with a physician or nurse practitioner via video, receive a pioglitazone prescription electronically, and fill it at any local pharmacy.

For patients using HealthRX or similar telehealth platforms, the workflow is straightforward: complete a medical intake, have lab work (fasting glucose, HbA1c, liver function panel) reviewed by the prescribing clinician, receive the electronic prescription, and fill at the Kansas pharmacy of choice. Dr. Robert Gabbay, Chief Scientific and Medical Officer at the American Diabetes Association, has noted: "Telehealth has become a permanent fixture in diabetes management, removing geographic barriers that previously limited access to endocrinology expertise" 5.

Savings Programs and Discount Options

Several pathways exist to reduce pioglitazone costs further in Kansas, even below the $15 average cash price.

Pharmacy discount clubs. Walmart's $4/$10 generic program (30-day/90-day) includes pioglitazone at many Kansas locations. Costco Pharmacy in Overland Park and Wichita offers competitive pricing to non-members (Kansas law does not require Costco membership to use the pharmacy). Hy-Vee pharmacies across Kansas participate in their own $4 generic program.

Discount card programs. GoodRx, RxSaver, and SingleCare coupons frequently bring pioglitazone below $10 for 30 tablets at Kansas pharmacies. These cards work for uninsured and underinsured patients and can sometimes beat insurance copays.

Manufacturer assistance. Takeda's patient assistance program (Takeda Help at Hand) provides brand Actos at no cost to qualifying uninsured patients with household income below 250% of the federal poverty level. For Kansas, where the 2026 FPL for a single individual is approximately $15,650, this means qualification at household income under $39,125.

340B pricing. Federally qualified health centers (FQHCs) in Kansas, including GraceMed Health Clinic (Wichita), Konza Prairie Community Health Center (Junction City), and Health Partnership Clinic (Olathe), dispense medications at 340B discounted prices. Pioglitazone through a 340B pharmacy may cost $0 to $5 per month for eligible patients 6.

State pharmaceutical assistance. Kansas does not operate a standalone state pharmaceutical assistance program (SPAP) for non-Medicare adults. However, Kansas Medicare Part D beneficiaries in the coverage gap (donut hole) pay no more than 25% coinsurance for generic pioglitazone under the Inflation Reduction Act provisions that capped out-of-pocket Part D costs at $2,000 annually starting in 2025.

Clinical Context for Cost Decisions

Pioglitazone's low cost in Kansas positions it as one of the most affordable second-line diabetes medications available. For context, a monthly supply of empagliflozin (Jardiance) costs $550 to $600 without insurance, and semaglutide (Ozempic) exceeds $900 per month at list price. Pioglitazone at $15 per month represents a 97% cost reduction compared to branded SGLT2 inhibitors or GLP-1 receptor agonists.

This cost advantage matters clinically because pioglitazone offers benefits beyond glycemic control. The IRIS trial (N=3,876) demonstrated that pioglitazone 45 mg daily reduced the risk of stroke or myocardial infarction by 24% (HR 0.76 to 95% CI 0.62-0.93) in insulin-resistant patients without diabetes who had experienced a recent ischemic stroke or TIA 7. The Endocrine Society's 2023 clinical practice guideline on MASH pharmacotherapy states: "Pioglitazone should be considered for patients with biopsy-confirmed NASH regardless of diabetes status, given its evidence base from PIVENS and cost accessibility" 8.

Patients and prescribers in Kansas weighing pioglitazone against newer, more expensive agents should consider the drug's established cardiovascular data, MASH benefit, insulin-sensitizing mechanism, and the fact that adherence improves when monthly costs are low. A 2022 retrospective cohort study (N=42,803) found that medication adherence for diabetes drugs priced under $20 per month was 23 percentage points higher than for drugs exceeding $100 per month (78% vs. 55% proportion of days covered ≥0.80) 9.

Safety Monitoring Costs in Kansas

Prescribing pioglitazone requires periodic monitoring that adds to total treatment cost. Kansas patients should budget for:

• Baseline liver function tests (ALT/AST): $15 to $40 at Quest or Labcorp Kansas locations
• Annual comprehensive metabolic panel: covered by most Kansas insurance as preventive care
• Periodic DEXA scan if fracture risk factors are present (pioglitazone reduces bone mineral density): $100 to $250 without insurance at Kansas imaging centers

The FDA labeling for pioglitazone recommends against use in patients with NYHA Class III or IV heart failure and advises monitoring for signs of fluid retention 1. Kansas clinicians should obtain baseline BNP or NT-proBNP in patients over 65 or those with known cardiac history before initiating therapy. Dr. Irl Hirsch, Professor of Medicine at the University of Washington, has stated: "Pioglitazone remains underused relative to its evidence base, largely due to class-effect concerns about heart failure that are manageable with proper patient selection and monitoring" 10.

How to Fill a Pioglitazone Prescription in Kansas

The process for Kansas residents is direct. A licensed physician (MD/DO), nurse practitioner (APRN), or physician assistant (PA) with prescriptive authority in Kansas writes the prescription. Kansas allows e-prescribing for all non-controlled medications.

Patients can fill at any of the approximately 1,200 licensed retail pharmacies in Kansas. Mail-order pharmacy is another option: Express Scripts, CVS Caremark, and OptumRx all ship to Kansas addresses. For 90-day mail-order supplies, patients often pay one copay for three months of medication.

Kansas does not restrict pioglitazone dispensing quantities. A prescriber may write for up to a 12-month supply with refills, though most insurance plans authorize 30-day or 90-day fills at a time.

Generic pioglitazone tablets are available in 15 mg, 30 mg, and 45 mg strengths. The combination product pioglitazone/metformin (ActoPlus Met) is also available generically in Kansas, typically priced at $20 to $30 per month for cash-pay patients.